Authors:
Veldman, RJ
Maestre, N
Aduib, OM
Medin, JA
Salvayre, R
Levade, T
Citation: Rj. Veldman et al., A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signalling, BIOCHEM J, 355, 2001, pp. 859-868
Authors:
Morjani, H
Aouali, N
Belhoussine, R
Veldman, RJ
Levade, T
Manfait, M
Citation: H. Morjani et al., Elevation of glucosylceramide in multidrug-resistant cancer cells and accumulation in cytoplasmic droplets, INT J CANC, 94(2), 2001, pp. 157-165
Authors:
Sietsma, H
Veldman, RJ
Van der Kolk, D
Ausema, B
Nijhof, W
Kamps, W
Vellenga, E
Kok, JW
Citation: H. Sietsma et al., 1-phenyl-2-decanoylamino-3-morpholino-1-propanol chemosensitizes neuroblastoma cells for taxol and vincristine, CLIN CANC R, 6(3), 2000, pp. 942-948
Authors:
Rodrigues-Lima, F
Fensomes, AC
Josephs, M
Evans, J
Veldman, RJ
Katan, M
Citation: F. Rodrigues-lima et al., Structural requirements for catalysis and membrane targeting of mammalian enzymes with neutral sphingomyelinase and lysophospholipid phospholipase C activities - Analysis by chemical modification and site-directed mutagenesis, J BIOL CHEM, 275(36), 2000, pp. 28316
Authors:
Veldman, RJ
Sietsma, H
Klappe, K
Hoekstra, D
Kok, JW
Citation: Rj. Veldman et al., Inhibition of P-glycoprotein activity and chemosensitization of multidrug-resistant ovarian carcinoma 2780AD cells by hexanoylglucosylceramide, BIOC BIOP R, 266(2), 1999, pp. 492-496